eprintid: 10146936 rev_number: 6 eprint_status: archive userid: 699 dir: disk0/10/14/69/36 datestamp: 2022-04-20 10:16:26 lastmod: 2022-04-20 10:16:26 status_changed: 2022-04-20 10:16:26 type: article metadata_visibility: show sword_depositor: 699 creators_name: Lo, J creators_name: Forst, AL creators_name: Warth, R creators_name: Zdebik, AA title: EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies ispublished: pub divisions: C08 divisions: G02 divisions: B02 divisions: UCL divisions: D09 keywords: EAST syndrome, SeSAME syndrome, KCNJ10, KCNJ16, channelopathy, deafness, distal convoluted tubule, epilepsy note: © 2022 Lo, Forst, Warth and Zdebik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. abstract: In 2009, two groups independently linked human mutations in the inwardly rectifying K+ channel Kir4.1 (gene name KCNJ10) to a syndrome affecting the central nervous system (CNS), hearing, and renal tubular salt reabsorption. The autosomal recessive syndrome has been named EAST (epilepsy, ataxia, sensorineural deafness, and renal tubulopathy) or SeSAME syndrome (seizures, sensorineural deafness, ataxia, intellectual disability, and electrolyte imbalance), accordingly. Renal dysfunction in EAST/SeSAME patients results in loss of Na+, K+, and Mg2+ with urine, activation of the renin–angiotensin–aldosterone system, and hypokalemic metabolic alkalosis. Kir4.1 is highly expressed in affected organs: the CNS, inner ear, and kidney. In the kidney, it mostly forms heteromeric channels with Kir5.1 (KCNJ16). Biallelic loss-of-function mutations of Kir5.1 can also have disease significance, but the clinical symptoms differ substantially from those of EAST/SeSAME syndrome: although sensorineural hearing loss and hypokalemia are replicated, there is no alkalosis, but rather acidosis of variable severity; in contrast to EAST/SeSAME syndrome, the CNS is unaffected. This review provides a framework for understanding some of these differences and will guide the reader through the growing literature on Kir4.1 and Kir5.1, discussing the complex disease mechanisms and the variable expression of disease symptoms from a molecular and systems physiology perspective. Knowledge of the pathophysiology of these diseases and their multifaceted clinical spectrum is an important prerequisite for making the correct diagnosis and forms the basis for personalized therapies. date: 2022-03-15 date_type: published publisher: Frontiers Media SA official_url: https://doi.org/10.3389/fphys.2022.852674 oa_status: green full_text_type: pub language: eng primo: open primo_central: open_green verified: verified_manual elements_id: 1949332 doi: 10.3389/fphys.2022.852674 medium: Electronic-eCollection lyricists_name: Zdebik, Anselm lyricists_id: AAZDE01 actors_name: Kalinowski, Damian actors_id: DKALI47 actors_role: owner full_text_status: public publication: Frontiers in Physiology volume: 13 article_number: 852674 event_location: Switzerland issn: 1664-042X citation: Lo, J; Forst, AL; Warth, R; Zdebik, AA; (2022) EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies. Frontiers in Physiology , 13 , Article 852674. 10.3389/fphys.2022.852674 <https://doi.org/10.3389/fphys.2022.852674>. Green open access document_url: https://discovery.ucl.ac.uk/id/eprint/10146936/1/Zdebik_EAST%3ASeSAME%20Syndrome%20and%20Beyond_VoR.pdf